Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin

Journal of Cell Biology

Volumn 189, Issue 4, 2010, Pages 691-700

  Sugawara, Yo ^a   Matsumura, Takuhiro ^a   Takegahara, Yuki ^a   Jin, Yingji ^a   Tsukasaki, Yoshikazu ^b   Takeichi, Masatoshi ^b   Fujinaga, Yukako ^a  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; HEMAGGLUTININ; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DISRUPTION; COMPLEX FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KIDNEY CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TIGHT JUNCTION;

ANIMALS; BOTULINUM TOXINS; CADHERINS; CATTLE; CELL ADHESION; CELL LINE; DOGS; EPITHELIAL CELLS; HEMAGGLUTININS; HUMANS; MICE; RATS;

BOVINAE; CLOSTRIDIUM BOTULINUM; RATTUS;

EID: 77952360192     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200910119     Document Type: Article

References (49)

1. Arnon, S.S., R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, J. Hauer, M. Layton, et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 285:1059-1070. doi:10.1001/jama.285.8.1059
2. Behrens, J., W. Birchmeier, S.L. Goodman, and B.A. Imhof. 1985. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J. Cell Biol. 101:1307-1315. doi:10.1083/jcb.101.4.1307 (Pubitemid 16203747)
3. Boggon, T.J., J. Murray, S. Chappuis-Flament, E. Wong, B.M. Gumbiner, and L. Shapiro. 2002. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science. 296:1308-1313. doi:10.1126/science.1071559
4. Capaldo, C.T., and I.G. Macara. 2007. Depletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells. Mol. Biol. Cell. 18:189-200. doi:10.1091/mbc.E06-05-0471
5. Citi, S. 1993. The molecular organization of tight junctions. J. Cell Biol. 121:485-489. doi:10.1083/jcb.121.3.485
6. Coffield, J.A., N. Bakry, R.D. Zhang, J. Carlson, L.G. Gomella, and L.L. Simpson. 1997. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches. J. Pharmacol. Exp. Ther. 280: 1489-1498.
7. Couesnon, A., Y. Pereira, and M.R. Popoff. 2008. Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cell. Microbiol. 10:375-387.
8. Disson, O., S. Grayo, E. Huillet, G. Nikitas, F. Langa-Vives, O. Dussurget, M. Ragon, A. Le Monnier, C. Babinet, P. Cossart, and M. Lecuit. 2008. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature. 455:1114-1118. doi:10.1038/nature07303
9. Farquhar, M.G., and G.E. Palade. 1963. Junctional complexes in various epithelia. J. Cell Biol. 17:375-412. doi:10.1083/jcb.17.2.375
10. Frank, C.F., and M.K. Hostetter. 2007. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl. Res. 149:211-222. doi:10.1016/j.trsl.2006.11.006
11. Furuse, M., K. Fujita, T. Hiiragi, K. Fujimoto, and S. Tsukita. 1998. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141:1539-1550. doi:10.1083/jcb.141.7.1539 (Pubitemid 28309169)
12. Gross, W.B., and L.D.S. Smith. 1971. Experimental botulism in gallinaceous birds. Avian Dis. 15:716-722. doi:10.2307/1588859
13. Gumbiner, B., and K. Simons. 1986. A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of a uvomorulin-like polypeptide. J. Cell Biol. 102:457-468. doi:10.1083/jcb.102.2. 457 (Pubitemid 16140806)
14. Gumbiner, B., B. Stevenson, and A. Grimaldi. 1988. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J. Cell Biol. 107:1575-1587. doi:10.1083/jcb.107.4.1575
15. Hatta, K., T.S. Okada, and M. Takeichi. 1985. A monoclonal antibody disrupting calcium-dependent cell-cell adhesion of brain tissues: possible role of its target antigen in animal pattern formation. Proc. Natl. Acad. Sci. USA. 82:2789-2793. doi:10.1073/pnas.82.9.2789
16. Häussinger, D., T. Ahrens, T. Aberle, J. Engel, J. Stetefeld, and S. Grzesiek. 2004. Proteolytic E-cadherin activation followed by solution NMR and X-ray crystallography. EMBO J. 23:1699-1708. doi:10.1038/sj.emboj.7600192 (Pubitemid 38649633)
17. Inai, T., A. Sengoku, E. Hirose, H. Iida, and Y. Shibata. 2008. Comparative characterization of mouse rectum CMT93-I and -II cells by expression of claudin isoforms and tight junction morphology and function. Histochem. Cell Biol. 129:223-232. doi:10.1007/s00418-007-0360-0
18. Jin, Y., Y. Takegahara, Y. Sugawara, T. Matsumura, and Y. Fujinaga. 2009. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology. 155:35-45. doi:10.1099/mic.0.021246-0
19. Kametani, Y., and M. Takeichi. 2007. Basal-to-apical cadherin flow at cell junctions. Nat. Cell Biol. 9:92-98. doi:10.1038/ncb1520 (Pubitemid 46024202)
20. Katz, J., V. Sambandam, J.H. Wu, S.M. Michalek, and D.F. Balkovetz. 2000. Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect. Immun. 68:1441-1449. doi:10.1128/ IAI.68.3.1441-1449.2000
21. Katz, J., Q.B. Yang, P. Zhang, J. Potempa, J. Travis, S.M. Michalek, and D.F. Balkovetz. 2002. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains. Infect. Immun. 70:2512-2518. doi:10.1128/IAI.70.5.2512-2518.2002
22. Kondoh, M., A. Masuyama, A. Takahashi, N. Asano, H. Mizuguchi, N. Koizumi, M. Fujii, T. Hayakawa, Y. Horiguchi, and Y. Watanbe. 2005. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol. 67:749-756. doi:10.1124/mol.104.008375 (Pubitemid 40365322)
23. Lecuit, M., S. Dramsi, C. Gottardi, M. Fedor-Chaiken, B. Gumbiner, and P. Cossart. 1999. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J. 18:3956-3963. doi:10.1093/emboj/18.14.3956 (Pubitemid 29335848)
24. Lecuit, M., S. Vandormael-Pournin, J. Lefort, M. Huerre, P. Gounon, C. Dupuy, C. Babinet, and P. Cossart. 2001. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science. 292:1722-1725. doi:10.1126/science.1059852
25. Maksymowych, A.B., and L.L. Simpson. 1998. Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J. Biol. Chem. 273:21950-21957. doi:10.1074/jbc.273.34.21950
26. Matsumura, T., Y. Jin, Y. Kabumoto, Y. Takegahara, K. Oguma, W.I. Lencer, and Y. Fujinaga. 2008. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell. Microbiol. 10:355-364.
27. Mengaud, J., H. Ohayon, P. Gounon, P. Cossart, R.-M. Mège, and P. Cossart. 1996. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell. 84:923-932. doi:10.1016/S0092-8674(00)81070-3 (Pubitemid 26106861)
28. Miyatani, S., K. Shimamura, M. Hatta, A. Nagafuchi, A. Nose, M. Matsunaga, K. Hatta, and M. Takeichi. 1989. Neural cadherin: role in selective cell-cell adhesion. Science. 245:631-635. doi:10.1126/science.2762814
29. Nagafuchi, A., Y. Shirayoshi, K. Okazaki, K. Yasuda, and M. Takeichi. 1987. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature. 329:341-343. doi:10.1038/329341a0
30. Neutra, M.R., N.J. Mantis, and J.P. Kraehenbuhl. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004-1009. doi:10.1038/ni1101-1004
31. Notermans, S., J. Dufrenne, and S. Kozaki. 1980. Experimental botulism in Pekin ducks. Avian Dis. 24:658-664. doi:10.2307/1589803
32. Obiso, R.J. Jr., A.O. Azghani, and T.D. Wilkins. 1997. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65:1431-1439.
33. Oguma, K., K. Inoue, Y. Fujinaga, K. Yokota, T. Watanabe, T. Ohyama, K. Takeshi, and K. Inoue. 1999. Structure and function of Clostridium botulinum progenitor toxin. Journal of Toxicololgy: Toxin Reviews. 18:17-34.
34. Ohishi, I., S. Sugii, and G. Sakaguchi. 1977. Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect. Immun. 16:107-109. (Pubitemid 8086702)
35. Ozawa, M., H. Baribault, and R. Kemler. 1989. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711-1717. (Pubitemid 19273986)
36. Ozawa, M., H. Hoschützky, K. Herrenknecht, and R. Kemler. 1990. A possible new adhesive site in the cell-adhesion molecule uvomorulin. Mech. Dev. 33:49-56. doi:10.1016/0925-4773(90)90134-8
37. Phan, Q.T., C.L. Myers, Y. Fu, D.C. Sheppard, M.R. Yeaman, W.H. Welch, A.S. Ibrahim, J.E. Edwards Jr., and S.G. Filler. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 5:e64. doi:10.1371/journal.pbio.0050064
38. Poulain, B., M.R. Popoff, and J. Molgó. 2008. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. The Botulinum J. 1:14-87. doi:10.1504/TBJ.2008.018951
39. Sakaguchi, G. 1982. Clostridium botulinum toxins. Pharmacol. Ther. 19:165-194. doi:10.1016/0163-7258(82)90061-4
40. Schiavo, G., M. Matteoli, and C. Montecucco. 2000. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80:717-766.
41. Shapiro, L., and W.I. Weis. 2009. Structure and biochemistry of cadherins and catenins. Cold Spring Harb. Perspect. Biol. 1:a003053. doi:10.1101/ cshperspect. a003053
42. Simpson, L.L. 2004. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44:167-193. doi:10.1146/annurev .pharmtox.44.101802.121554 (Pubitemid 38263838)
43. Sonoda, N., M. Furuse, H. Sasaki, S. Yonemura, J. Katahira, Y. Horiguchi, and S. Tsukita. 1999. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147:195-204. doi:10.1083/jcb.147.1.195 (Pubitemid 30211807)
44. Sugii, S., I. Ohishi, and G. Sakaguchi. 1977. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect. Immun. 16:910-914. (Pubitemid 8112763)
45. Villar, C.C., H. Kashleva, C.J. Nobile, A.P. Mitchell, and A. Dongari-Bagtzoglou. 2007. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun. 75:2126-2135. doi:10.1128/IAI.00054-07
46. Watabe, M., A. Nagafuchi, S. Tsukita, and M. Takeichi. 1994. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 127:247-256. doi:10.1083/jcb.127.1.247 (Pubitemid 24307671)
47. Wu, S., K.C. Lim, J. Huang, R.F. Saidi, and C.L. Sears. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA. 95:14979-14984. doi:10.1073/pnas.95.25.14979
48. Yagi, T., and M. Takeichi. 2000. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 14:1169-1180. (Pubitemid 30327498)
49. Yoshida-Noro, C., N. Suzuki, and M. Takeichi. 1984. Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody. Dev. Biol. 101:19-27. doi:10.1016/0012-1606(84)90112-X